Press Kit
Resources for journalists & partners.
Logos, product photography, executive bios, and a short company description. For interviews or asset variants not listed here, please get in touch.
Boilerplate
For inclusion in articles and press releases. Please use as written.
Leuko Labs Inc. is developing PointCheck™, the first noninvasive device for monitoring white blood cell levels at home, without a blood draw. An MIT spin-out backed by NIH/NCI grants and Series A investors, Leuko is headquartered in Cambridge, Massachusetts with European operations in Madrid, Spain. PointCheck™ is an investigational device. It is not for sale.
Last updated May 2026.
Logos
Use the Leuko wordmark to refer to the company; use the PointCheck™ wordmark when specifically referring to the product. Maintain clear space equal to the cap-height of the mark on all sides. Do not recolor, distort, or place on low-contrast backgrounds.
-
Leuko wordmark
Download PNG ↓ -
PointCheck™ wordmark
Download PNG ↓
SVG and dark-on-light / light-on-dark variants are available on request.
Product photography
High-resolution photography of PointCheck™. Please credit “Courtesy of Leuko Labs Inc.” when used.
-
PointCheck™ in use at home
Download ↓ -
PointCheck™ device renders
Download ↓
Executive bios
Short biographies of the Leuko executive team. Headshots available on request.
-
Carlos Castro Gonzalez, PhD
Chief Executive Officer
15+ yrs biomedical engineer & medtech innovator; led customer discovery, strategic partnerships, fundraising, and go-to-market; MIT-trained; prior medtech startup experience.
-
Ian Butterworth, MSc
Chief Technology Officer
15+ yrs building medical device hardware, electronics & software into commercial-grade products; MIT research engineer; prior medtech startup experience.
-
Aurelien Bourquard, PhD
Chief Data Scientist
15+ yrs in AI for biomedical imaging; built & deployed production-grade algorithms for medical devices at scale; EPFL & MIT trained; cutting edge peer-reviewed publication record.
-
Alvaro Sanchez-Ferro, MD, PhD
Chief Medical Officer
20+ yrs clinical practice, led clinical study design and execution for regulatory and clinical adoption of medical devices; MIT-trained; prior medtech startup experience.